• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血酶生成与癌症发病机制

Thrombin generation and the pathogenesis of cancer.

作者信息

Ruf Wolfram, Mueller Barbara M

机构信息

Scripps Research Institute and the La Jolla Institute for Molecular Medicine, San Diego, California 92037, USA.

出版信息

Semin Thromb Hemost. 2006 Apr;32 Suppl 1:61-8. doi: 10.1055/s-2006-939555.

DOI:10.1055/s-2006-939555
PMID:16673267
Abstract

Advanced cancer is associated with a hypercoagulable state that is triggered by tissue factor (TF). TF-initiated thrombin generation is crucial for metastasis through fibrin and platelet deposition, as well as thrombin-dependent protease-activated receptor (PAR) 1 signaling. Surprisingly, PAR2, which is not cleaved by thrombin, appears to cosignal with PAR1 to elicit thrombin effects in metastatic tumor cells. In contrast to TF-driven thrombin pathways in metastasis, direct TF signaling plays a role in angiogenesis-dependent tumor growth. In TF cytoplasmic-domain-deleted mice, PAR2-dependent angiogenesis and tumor growth is enhanced, demonstrating a role for host cell TF signaling. In tumor cells, TF-factor VIIa (FVIIa) activates PAR2 and thereby regulates proangiogenic growth factor expression as well as integrins involving crosstalk with the TF cytoplasmic domain. In addition to thrombin-PAR signaling in metastasis and TF-FVIIa-PAR2 signaling in tumor growth, it is likely that additional protease pathways will prove to be crucial activators of PARs in cancer. Transmembrane serine proteases as well as matrix metalloproteinase are prime candidates for accessory pathways to regulate metastasis, tumor expansion, and angiogenesis dependent on specific features of the local tumor microenvironment.

摘要

晚期癌症与由组织因子(TF)引发的高凝状态相关。TF启动的凝血酶生成对于通过纤维蛋白和血小板沉积以及凝血酶依赖性蛋白酶激活受体(PAR)1信号传导的转移至关重要。令人惊讶的是,不被凝血酶切割的PAR2似乎与PAR1共同发出信号,以在转移性肿瘤细胞中引发凝血酶效应。与转移中TF驱动的凝血酶途径相反,直接TF信号传导在血管生成依赖性肿瘤生长中起作用。在TF胞质结构域缺失的小鼠中,PAR2依赖性血管生成和肿瘤生长增强,表明宿主细胞TF信号传导的作用。在肿瘤细胞中,TF-因子VIIa(FVIIa)激活PAR2,从而调节促血管生成生长因子的表达以及涉及与TF胞质结构域相互作用的整合素。除了转移中的凝血酶-PAR信号传导和肿瘤生长中的TF-FVIIa-PAR2信号传导外,很可能其他蛋白酶途径将被证明是癌症中PARs的关键激活剂。跨膜丝氨酸蛋白酶以及基质金属蛋白酶是调节转移、肿瘤扩展和依赖于局部肿瘤微环境特定特征的血管生成辅助途径的主要候选者。

相似文献

1
Thrombin generation and the pathogenesis of cancer.凝血酶生成与癌症发病机制
Semin Thromb Hemost. 2006 Apr;32 Suppl 1:61-8. doi: 10.1055/s-2006-939555.
2
Regulation of angiogenesis by tissue factor cytoplasmic domain signaling.组织因子胞质结构域信号传导对血管生成的调控。
Nat Med. 2004 May;10(5):502-9. doi: 10.1038/nm1037. Epub 2004 Apr 18.
3
Tissue factor--a receptor involved in the control of cellular properties, including angiogenesis.组织因子——一种参与控制细胞特性(包括血管生成)的受体。
Thromb Haemost. 2001 Jul;86(1):334-45.
4
Tissue factor and fibrin in tumor angiogenesis.肿瘤血管生成中的组织因子与纤维蛋白
Semin Thromb Hemost. 2004 Feb;30(1):31-44. doi: 10.1055/s-2004-822969.
5
Tissue factor and protease-activated receptor signaling in cancer.癌症中的组织因子与蛋白酶激活受体信号传导
Semin Thromb Hemost. 2008 Mar;34(2):147-53. doi: 10.1055/s-2008-1079254.
6
Role of protease-activated receptor 1 in tumor metastasis promoted by tissue factor.蛋白酶激活受体1在组织因子促进肿瘤转移中的作用
Thromb Haemost. 2001 Nov;86(5):1210-4.
7
Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis.蛋白酶激活受体(PAR1和PAR2)有助于肿瘤细胞的运动和转移。
Mol Cancer Res. 2004 Jul;2(7):395-402.
8
Tissue factor and PAR signaling in tumor progression.组织因子与PAR信号传导在肿瘤进展中的作用
Thromb Res. 2007;120 Suppl 2:S7-12. doi: 10.1016/S0049-3848(07)70125-1.
9
Genetic determinants of cancer coagulopathy, angiogenesis and disease progression.癌症凝血病、血管生成及疾病进展的遗传决定因素。
Vnitr Lek. 2006 Mar;52 Suppl 1:135-8.
10
Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.蛋白酶激活受体-2对于因子VIIa和Xa诱导的乳腺癌细胞信号传导、迁移及侵袭至关重要。
Cancer Res. 2006 Jan 1;66(1):307-14. doi: 10.1158/0008-5472.CAN-05-1735.

引用本文的文献

1
Inhibition of Cancer Cell Migration and Invasion In Vitro by Recombinant Tyrosine-Sulfated Haemathrin, A Thrombin Inhibitor.重组酪氨酸硫酸化血纤维蛋白溶酶原激活物抑制剂体外抑制肿瘤细胞迁移和侵袭。
Int J Mol Sci. 2024 Nov 4;25(21):11822. doi: 10.3390/ijms252111822.
2
Metastasis and angiogenesis in cervical cancer: key aspects of purinergic signaling in platelets and possible therapeutic targets.宫颈癌的转移和血管生成:血小板嘌呤能信号转导的关键方面及可能的治疗靶点。
Purinergic Signal. 2024 Dec;20(6):607-616. doi: 10.1007/s11302-024-10020-3. Epub 2024 May 16.
3
Interactions between Platelets and Tumor Microenvironment Components in Ovarian Cancer and Their Implications for Treatment and Clinical Outcomes.
卵巢癌中血小板与肿瘤微环境成分之间的相互作用及其对治疗和临床结果的影响。
Cancers (Basel). 2023 Feb 17;15(4):1282. doi: 10.3390/cancers15041282.
4
Prognostic Role of Preoperative D-dimer Levels in Patients With Stage I-III Colorectal Cancer.术前D-二聚体水平在Ⅰ-Ⅲ期结直肠癌患者中的预后作用
Cancer Diagn Progn. 2023 Jan 3;3(1):38-43. doi: 10.21873/cdp.10177. eCollection 2023 Jan-Feb.
5
Roles of platelets in tumor invasion and metastasis: A review.血小板在肿瘤侵袭和转移中的作用:综述
Heliyon. 2022 Dec 5;8(12):e12072. doi: 10.1016/j.heliyon.2022.e12072. eCollection 2022 Dec.
6
Tinzaparin-a review of its molecular profile, pharmacology, special properties, and clinical uses.亭扎肝素——其分子特性、药理学、特殊性质和临床应用的综述。
Eur J Clin Pharmacol. 2022 Oct;78(10):1555-1565. doi: 10.1007/s00228-022-03365-4. Epub 2022 Jul 23.
7
Enhanced Thrombin Generation Is Associated with Worse Left Ventricular Scarring after ST-Segment Elevation Myocardial Infarction: A Cohort Study.增强的凝血酶生成与ST段抬高型心肌梗死后更严重的左心室瘢痕形成相关:一项队列研究。
Pharmaceuticals (Basel). 2022 Jun 6;15(6):718. doi: 10.3390/ph15060718.
8
Laser Photobiomodulation 808 nm: Effects on Gene Expression in Inflammatory and Osteogenic Biomarkers in Human Dental Pulp Stem Cells.808纳米激光光生物调节作用:对人牙髓干细胞中炎症和成骨生物标志物基因表达的影响
Front Pharmacol. 2022 Jan 17;12:782095. doi: 10.3389/fphar.2021.782095. eCollection 2021.
9
An Insight into GPCR and G-Proteins as Cancer Drivers.G 蛋白偶联受体(GPCR)和 G 蛋白作为癌症驱动因素的深入了解。
Cells. 2021 Nov 24;10(12):3288. doi: 10.3390/cells10123288.
10
Anticoagulation with Factor Xa Inhibitors Is Associated with Improved Overall Response and Progression-Free Survival in Patients with Metastatic Malignant Melanoma Receiving Immune Checkpoint Inhibitors-A Retrospective, Real-World Cohort Study.在接受免疫检查点抑制剂治疗的转移性恶性黑色素瘤患者中,使用Xa因子抑制剂进行抗凝治疗与总体缓解率提高和无进展生存期延长相关——一项回顾性真实世界队列研究。
Cancers (Basel). 2021 Oct 12;13(20):5103. doi: 10.3390/cancers13205103.